IL15 and neoplasm: Notably, the combination of IL-15 stimulation and PD-1 blockade resulted in the most pronounced tumor regression in all treated TIL-PDX-LUAD mice, demonstrating that IL-15 stimulation prevents tumor escape from ICI and augments antitumor immunity.